News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Policy
U.S. FDA Warns Gilead Sciences, Inc., Biogen Idec, Inc. (Massachusetts) Over Drug Promotions
April 8, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- U.S. health regulators warned Gilead Sciences (GILD.O), Biogen Idec (BIIB.O) and other drugmakers on Wednesday over misleading promotions for various products.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Gilead Sciences, Inc.
Food and Drug Administration (FDA)
Biogen
MORE ON THIS TOPIC
Drug pricing
Trump’s Drug Pricing Order ‘More Bark Than Bite’
May 12, 2025
·
5 min read
·
Annalee Armstrong
Drug pricing
White House Unwraps Massive Drug Pricing Policy, Touching All Corners of Pharma
May 12, 2025
·
6 min read
·
Annalee Armstrong
Legal
BMS, Sanofi Settle Plavix Suit With Hawaii for $700M
May 12, 2025
·
2 min read
·
Tristan Manalac
Vaccines
FDA, EU Flag Safety Issues With Valneva’s Chikungunya Vaccine
May 12, 2025
·
2 min read
·
Tristan Manalac